The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

H Tunstall-Pedoe | V Tikhonoff | A Hofman | Ryan L. Collins | H Nakagawa | R B D'Agostino | E Casiglia | S G Thompson | Y Ben-Shlomo | P A Wolf | S M Cobbe | I R White | F Rodeghiero | J E Keil | I Ford | D Kromhout | J M Dekker | L M Bouter | B V Howard | I Jungner | L Wilhelmsen | J Gallacher | B M Psaty | J Jespersen | J Shepherd | Jonathan A. Cooper | J. Gallacher | J. Danesh | R. Collins | C. Meisinger | A. Hofman | J. Manson | E. Rimm | V. Salomaa | E. Vartiainen | T. Jørgensen | M. Pencina | R. D'Agostino | P. Wolf | G. Dagenais | E. Feskens | M. Woodward | H. Tunstall-Pedoe | P. Ridker | R. Vasan | I. White | A. Wood | J. Després | X. Jouven | J. Buring | A. Folsom | L. Chambless | J. Witteman | L. Kuller | J. Guralnik | B. Psaty | E. Barrett-Connor | B. Howard | N. Sattar | S. Hankinson | D. Blazer | D. Blazer | M. Trevisan | M. Stampfer | A. Evans | D. Arveiler | A. Döring | V. Tikhonoff | E. Casiglia | L. Bouter | R. Gillum | G. Berglund | P. Jousilahti | B. Hedblad | J. Salonen | P. Amouyel | G. Nijpels | J. Dekker | R. Heine | B. Nordestgaard | G. Sigurdsson | S. Kiechl | J. Willeit | T. Strandberg | H. Concin | P. Ducimetiere | Gunnar Sigurdsson | S. Ebrahim | M. Mussolino | M. Breteler | G. Assmann | H. Schulte | S. Wannamethee | G. Lowe | D. Wingard | U. Goldbourt | W. Koenig | G. Engström | E. Mathiesen | J. Gaziano | I. Holme | N. Wald | I. Njølstad | T. Wilsgaard | T. Aspelund | Y. Friedlander | T. Meade | Y. Ben-Shlomo | L. Wilhelmsen | N. Sarwar | K. Khaw | J. Ferrières | C. Björkelund | A. Rosengren | E. Brunner | I. Kardys | S. Kaptoge | E. Angelantonio | F. Fowkes | A. Chetrit | R. Dankner | C. Donfrancesco | S. Giampaoli | D. Kromhout | A. Onat | L. Palmieri | L. Pilotto | L. Simons | T. Tuomainen | H. Ulmer | D. Vanuzzo | S. Thompson | M. Cushman | I. Ford | E. Di Angelantonio | R. Frikke-Schmidt | J. Jansson | C. Packard | A. Tybjaerg-hansen | R. Morris | S. Panico | H. Iso | J. Yarnell | C. Stehouwer | M. Knuiman | B. D. De Stavola | S. Lewington | R. Tracy | M. Løchen | M. García-palmieri | A. Kitamura | J. Cooper | K. Nyyssönen | P. Santer | D. Deeg | A. Tosetto | R. Tilvis | G. Walldius | J. Pai | C. Phillips | S. Sutherland | K. Bauer | R. Rosenberg | W. Nystad | J. Shepherd | S. Cobbe | J. Jespersen | H. Nakagawa | C. Crespo | R. Bettencourt | F. Rodeghiero | A. Tybjærg‐Hansen | H. Noda | B. Lamarche | A. Tverdal | G. Lappas | E. Bladbjerg | S. Pressel | P. Whincup | W. Mraz | D. Nagel | A. Lee | B. Rodríguez | K. Ray | P. Cremer | S. Sato | V. Gudnason | H. Eriksson | L. Pennells | Shinichi Sato | I. Jungner | F. Wensley | D. Lawlor | B. Thórsson | Y. Naito | M. Stampfer | A. Thompson | W Nystad | P H Whincup | N Sattar | M Trevisan | S Giampaoli | B. Nordestgaard | E Barrett-Connor | G D O Lowe | A Döring | C Meisinger | A J Lee | M Woodward | M Cushman | R P Tracy | R J Heine | R Tipping | P Ridker | J T Salonen | K Nyyssönen | G Sigurdsson | G Berglund | H Schulte | G Assmann | D Blazer | A R Folsom | P Amouyel | S Pressel | J. Mccallum | G. Diem | R Collins | F. B. Smith | E Vartiainen | John A. Taylor | M. Shipley | K A Bauer | R D Rosenberg | E Brunner | L Kuller | A Chetrit | Y Friedlander | G R Dagenais | V Salomaa | J A Cooper | U Goldbourt | B Hedblad | K. Khaw | J. Keil | X Jouven | F G R Fowkes | J Buring | C D A Stehouwer | R. Wallace | P Cremer | S Ebrahim | F Lubin | D Nagel | W Koenig | T Aspelund | L Palmieri | S Kaptoge | J H Jansson | P Jousilahti | K T Khaw | J M Gaziano | B Lamarche | B Cantin | L E Chambless | J. Umans | M. Robertson | S G Wannamethee | S E Sutherland | R. Tavendale | S. Erqou | B. Cantin | E Rimm | R Tilvis | D Arveiler | J Willeit | S Kiechl | N Wald | A Onat | H Iso | E J M Feskens | I Holme | H Eriksson | R Wallace | R. Bettencourt | G Walldius | J W G Yarnell | A Tybjaerg-Hansen | F B Smith | K Harald | A Rosengren | G Lappas | B Rodriguez | T-P Tuomainen | T W Meade | B De Stavola | C Knottenbelt | S Sato | A Kitamura | Y Naito | P Ducimetiere | J Ferrieres | A Tosetto | M Robertson | M Shipley | E Di Angelantonio | S Lewington | N Sarwar | S Watson | A M Wood | J Danesh | R Gillum | R. Selmer | J-P Després | L. Orfei | D A Lawlor | J McCallum | G Nijpels | J Guralnik | C Phillips | J Cooper | R Tavendale | K. Harald | M. Walker | R. Tipping | C. Ford | A. Mayr | P. Nietert | D. Bachman | S. Panico | J. Taylor | R. S. Vasan | L. Møller | F. Lubin | C. Bjorkelund | J. L. Poppelaars | G. Engstrom | C. Knottenbelt | H. Miura | M. Garcia-Palmieri | Y. Zhang | L. Best | Y. He | A. M. Ibáñez | P. Perry | M. Scherman | S. Watson | B G Nordestgaard | A Tverdal | A. Mayr | V Gudnason | S Erqou | M Walker | C Ford | M Knuiman | R W Morris | P Santer | A Mayr | P J Nietert | D L Bachman | R Frikke-Schmidt | S Panico | D Vanuzzo | L Pilotto | L Simons | J Taylor | C Donfrancesco | R S Vasan | M J Pencina | E M Bladbjerg | T Jorgensen | L Moller | R Dankner | C Bjorkelund | T Strandberg | J Pai | H Noda | D Deeg | J L Poppelaars | T Meade | G Engstrom | W Mraz | R Selmer | M Mussolino | S Hankinson | J Manson | H Miura | C Crespo | M Garcia-Palmieri | A Evans | C Packard | D Wingard | R Bettencourt | B Thorsson | J Witteman | I Kardys | M Breteler | Y Zhang | L Best | J Umans | I Njolstad | E Mathiesen | M L Lochen | T Wilsgaard | M Stampfer | H Ulmer | G Diem | H Concin | Y He | A M Ibanez | L Orfei | L Pennells | P Perry | K Ray | M Scherman | A Thompson | F Wensley | L. Møller | Yonghan He | W. Koenig | T. Jørgensen | R. Vasan | M. Walker | M. Woodward | J. Keil | K. Nyyssönen | H. Ulmer | M. Trevisan | G. Assmann | A. Hofman | A. Lee | A. J. Lee | I. Ford | B. Stavola | D. Lawlor | Dorly JH Deeg | Tuomainen T-P. | Stehouwer Cda. | Fowkes Fgr. | Barbara V. Howard | N. Wald | A. Evans | Julie E. Buring | R. B. Wallace | Angela Döring | A. M. Ibañez | F. Smith | B. Psaty | R. D’Agostino | David L. Bachman | S. Sato | Yarnell Jwg. | H. Nakagawa | Després J-P. | Lowe Gdo. | Feskens Ejm. | J. Cooper | Dorly J.H. Deeg | S. Wannamethee | B. L. Stavola | Frances Wensley

[1]  J. Danesh,et al.  Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. , 2007, American journal of epidemiology.

[2]  B. Nordestgaard,et al.  Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B: The Copenhagen City Heart Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[3]  J. Danesh,et al.  Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.

[4]  Meta-Analysis Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies , 2007 .

[5]  M. Woodward,et al.  Cohort profile: the Asia Pacific Cohort Studies Collaboration. , 2006, International journal of epidemiology.

[6]  J. Danesh,et al.  Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. , 2006, International journal of epidemiology.

[7]  R. Sega,et al.  Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  Nancy R Cook,et al.  The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.

[9]  R. Sega,et al.  Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples. , 2006, American journal of epidemiology.

[10]  J. Danesh,et al.  Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature‐based meta‐analysis of prospective studies , 2006, Journal of internal medicine.

[11]  M. Medrano,et al.  Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting , 2006, BMC public health.

[12]  D. Wald.  Serum homocysteine and coronary heart disease , 2005 .

[13]  V. Salomaa,et al.  Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. , 2005, American journal of epidemiology.

[14]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[15]  J. Manson,et al.  Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? , 2005, European heart journal.

[16]  C. Meisinger,et al.  Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. , 2005, European heart journal.

[17]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[18]  D. Gordon,et al.  High-Density Lipoprotein Cholesterol and Cardiovascular Disease , 2005 .

[19]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[20]  J. Danesh,et al.  Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. , 2004, European heart journal.

[21]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[22]  L. Weinehall,et al.  Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[23]  Alicja R. Rudnicka,et al.  Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[24]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995. , 2004, Atherosclerosis. Supplements.

[25]  The Propafenone Research Group.  Presentation of the rifle project risk factors and life expectancy , 2004, European Journal of Epidemiology.

[26]  A. Hofman,et al.  Spatial QRS-T angle predicts cardiac death in a general population. , 2003, European heart journal.

[27]  H. Concin,et al.  Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme. , 2003, European heart journal.

[28]  P. Adab,et al.  Age-specific relevance of usual blood pressure to vascular mortality , 2003, The Lancet.

[29]  K. Miura,et al.  High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study , 2003, Stroke.

[30]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[31]  M. Arteaga-Vizcaíno,et al.  Factores Hemostáticos de Riesgo Coronario en una Población Sana de la Ciudad de Maracaibo, Venezuela , 2003 .

[32]  K. Eriksson,et al.  Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. , 2003, Diabetes.

[33]  C. Meisinger,et al.  C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. , 2003, Archives of internal medicine.

[34]  M. Diez‐Ewald,et al.  [Hemostatic coronary risk factors in a healthy population of Maracaibo, Venezuela]. , 2003, Investigacion clinica.

[35]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[36]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[37]  D. Lawlor,et al.  The association between components of adult height and Type II diabetes and insulin resistance: British Women's Heart and Health Study , 2002, Diabetologia.

[38]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆ , 2002 .

[39]  J. Smit,et al.  Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. , 2002, Journal of clinical epidemiology.

[40]  G. Dagenais,et al.  Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). , 2002, The American journal of cardiology.

[41]  H. Boshuizen,et al.  Predicting cardiovascular risk in the elderly in different European countries. , 2002, European heart journal.

[42]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[43]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study , 2001, The Lancet.

[44]  J. Ruidavets,et al.  Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. , 2001, International journal of epidemiology.

[45]  T. Meade.  Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621] , 2001, Current controlled trials in cardiovascular medicine.

[46]  A. Onat.  Risk factors and cardiovascular disease in Turkey. , 2001, Atherosclerosis.

[47]  H. Iso,et al.  Serum triglycerides and risk of coronary heart disease among Japanese men and women. , 2001, American journal of epidemiology.

[48]  M. Epidemiology.  Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease , 2001 .

[49]  N Rifai,et al.  Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. , 2001, The American journal of clinical nutrition.

[50]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[51]  H. Iso,et al.  Plasma fibrinogen and coronary heart disease in urban Japanese. , 2000, American journal of epidemiology.

[52]  S. Fortmann,et al.  Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). , 2000, The American journal of cardiology.

[53]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[54]  T. Lakka,et al.  Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2000, Archives of internal medicine.

[55]  E. Vartiainen,et al.  Cardiovascular risk factor changes in Finland, 1972-1997. , 2000, International journal of epidemiology.

[56]  A. Sjøl,et al.  Tissue‐type plasminogen activator and C‐reactive protein in acute coronary heart disease. A nested case–control study , 2000, Journal of internal medicine.

[57]  L. Wilhelmsen,et al.  Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943 , 2000, Journal of internal medicine.

[58]  Ames,et al.  PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .

[59]  P. Macfarlane,et al.  The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. , 1999, The American journal of cardiology.

[60]  R. Collins,et al.  Collaborative overview (‘Meta-Analysis’) of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration , 1999, Journal of cardiovascular risk.

[61]  R. Collins,et al.  Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.

[62]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[63]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[64]  J. Haddow,et al.  Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. , 1998, Clinical chemistry.

[65]  E. Casiglia,et al.  Cardiovascular risk factors in the elderly , 1998, Journal of Human Hypertension.

[66]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[67]  A. Chetrit,et al.  Methodology of a two-step quantified nutritional questionnaire and its effect on results. , 1998, Nutrition and cancer.

[68]  T. Lam,et al.  Mortality attributable to cigarette smoking in China. , 1997, JAMA.

[69]  S. Johansson,et al.  Risk factors for cardiovascular disease during the period 1985–1995 in Göteborg, Sweden. The GOT‐MONICA Project , 1997, Journal of internal medicine.

[70]  A. Gotto,et al.  Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 1997, The American journal of cardiology.

[71]  A. Tosetto,et al.  The VITA Project: Population-based Distributions of Protein C, Antithrombin III, Heparin-cofactor II and Plasminogen -Relationship with Physiological Variables and Establishment of Reference Ranges , 1996, Thrombosis and Haemostasis.

[72]  J. Cooper,et al.  Increased Activation of the Haemostatic System in Men at High Risk of Fatal Coronary Heart Disease , 1996, Thrombosis and Haemostasis.

[73]  J. Hokanson,et al.  Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.

[74]  A. Kagan.  The Honolulu heart program : an epidemiological study of coronary heart disease and stroke , 1996 .

[75]  T. Welborn,et al.  Age and secular trends in risk factors for cardiovascular disease in Busselton. , 2010, Australian journal of public health.

[76]  R. Norton,et al.  Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findings. , 1995, The New Zealand medical journal.

[77]  H. Valkenburg,et al.  Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study , 1995, Diabetes Care.

[78]  V. Salomaa,et al.  Haemostatic Factors and Lipoprotein (a) in Three Geographical Areas in Finland: The Finrisk Haemostasis Study , 1994, Journal of cardiovascular risk.

[79]  P. Elwood,et al.  Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. , 1994, British heart journal.

[80]  P. Elwood,et al.  Associations of the HDL2 and HDL3 Cholesterol Subfractions With the Development of Ischemic Heart Disease in British Men: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1994, Circulation.

[81]  R. Muche,et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.

[82]  N. Wald,et al.  Apolipoproteins and ischaemic heart disease: implications for screening , 1994, The Lancet.

[83]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[84]  I. Holme,et al.  The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality. A 12‐year follow‐up of the Oslo Study, Norway , 1993, Journal of internal medicine.

[85]  E. Barrett-Connor,et al.  Prevalence of Cardiovascular and Renal Complications in Older Adults With Normal or Impaired Glucose Tolerance or NIDDM: A population-based study , 1993, Diabetes Care.

[86]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[87]  J. Cleeman,et al.  Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. , 1993, JAMA.

[88]  S. Kiechl,et al.  Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[89]  J. Heikkilä,et al.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.

[90]  J. Kohout,et al.  Established populations for epidemiologic studies of the elderly: Study design and methodology , 1993, Aging.

[91]  M. Trevisan,et al.  Presentation of the Rifle Project Risk-Factors and Life Expectancy , 1993 .

[92]  P. Roderick,et al.  Extra-Cranial Bleeding and Other Symptoms due to Low Dose Aspirin and Low Intensity Oral Anticoagulation , 1992, Thrombosis and Haemostasis.

[93]  U. Keil,et al.  Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[94]  G. Thorgeirsson,et al.  Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. , 1992, The American journal of cardiology.

[95]  R. Gillum,et al.  Serum albumin, coronary heart disease, and death. , 1992, American heart journal.

[96]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[97]  R. Rauramaa,et al.  HDL, HDL2, and HDL3 Subfractions, and the Risk of Acute Myocardial Infarction: A Prospective Population Study in Eastern Finnish Men , 1991, Circulation.

[98]  Gower Street,et al.  Health inequalities among British civil servants: the Whitehall II study , 1991, The Lancet.

[99]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[100]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[101]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[102]  P. Allhoff,et al.  The Puerto Rico Heart Health Program , 1991 .

[103]  P. Allhoff,et al.  The Framingham Offspring Study , 1991 .

[104]  R. Rauramaa,et al.  HDL, HDL_2, and HDL_3 subfractions, and the risk of acute myocardial infarction , 1991 .

[105]  J. Simons,et al.  The Dubbo study: an Australian prospective community study of the health of elderly. , 1990, Australian and New Zealand journal of medicine.

[106]  P. Savage,et al.  The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. , 1990, American journal of epidemiology.

[107]  L. Wilhelmsen,et al.  Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. , 1990, BMJ.

[108]  I. Holme,et al.  Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. , 1989, American journal of epidemiology.

[109]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[110]  Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.

[111]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[112]  I. Crombie,et al.  The Scottish Heart Health Study: objectives and development of methods. , 1987, Health bulletin.

[113]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[114]  M. Weinrich,et al.  Incidence of coronary heart disease in blacks in Charleston, South Carolina. , 1984, American heart journal.

[115]  Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. , 1982, JAMA.

[116]  S J Pocock,et al.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. , 1981, British medical journal.

[117]  S Greenland,et al.  The effect of misclassification in the presence of covariates. , 1980, American journal of epidemiology.

[118]  F. Cambien,et al.  CORONARY HEART DISEASE IN MIDDLE-AGED FRENCHMEN Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project , 1980, The Lancet.

[119]  D. Jacobs,et al.  Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[120]  J. Medalie,et al.  High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. , 1979, American journal of epidemiology.

[121]  D. Thelle,et al.  The Tromsøo heart study. Methods and main results of the cross-sectional study. , 2009, Acta medica Scandinavica.

[122]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[123]  Oxon Dm.  Obituary. Rupert Samuel Bruce Pearson. , 1974 .

[124]  J. Gerrard,et al.  Letter: Sex-linked mental retardation. , 1974, Lancet.

[125]  B. Isaksson,et al.  The study of women in Gothenburg 1968-1969--a population study. General design, purpose and sampling results. , 2009, Acta medica Scandinavica.

[126]  M. García-palmieri,et al.  An epidemiological study on coronary heart disease in Puerto Rico: The Puerto Rico Heart Health Program. , 1969, Boletin de la Asociacion Medica de Puerto Rico.

[127]  D.,et al.  Regression Models and Life-Tables , 2022 .